Filed: 5/15/2023ACC: 0000950123-23-005049
📋 What this filing means
MWG MANAGEMENT LTD. filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $142.03M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$142.03M
Total AUM (reported)
24.35M
Total Shares
Allocation by class
COM$142.03M100.0%
Portfolio Concentration
Top 3$142.03M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 24.35M
Sole
Full voting authority
24.35M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other3
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
BEAM THERAPEUTICS INC
DFNDShares2.35M
TypeSH
Market value$71.86M
50.60%
Sole
2.35M
Shared
0.00
None
0.00
LYELL IMMUNOPHARMA INC
DFNDShares20.16M
TypeSH
Market value$47.58M
33.50%
Sole
20.16M
Shared
0.00
None
0.00
PRIME MEDICINE INC
DFNDShares1.84M
TypeSH
Market value$22.58M
15.90%
Sole
1.84M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BEAM THERAPEUTICS INCDFND | COM | 2.35M | SH | $71.86M 50.60% | 2.35M | 0.00 | 0.00 |
LYELL IMMUNOPHARMA INCDFND | COM | 20.16M | SH | $47.58M 33.50% | 20.16M | 0.00 | 0.00 |
PRIME MEDICINE INCDFND | COM | 1.84M | SH | $22.58M 15.90% | 1.84M | 0.00 | 0.00 |